Company intelligence / Profile preview

JBM Healthcare

Hong Kong, Hong Kong SAR Chinajbmhealthcare.com.hk ↗

Ownership: Private
Development stage: Commercial

Overview

JBM Healthcare has a broad commercial portfolio of branded consumer healthcare products and proprietary Chinese medicines. Its AIM Atropine Eye Drops lead the Hong Kong market for pediatric myopia control. The company also distributes the Oncotype DX® Breast Cancer Recurrence Score Test for early-stage breast cancer patients. Financially robust with strong revenue growth (+21% YoY FY2025), high profit margins (~25%), and a growing regional presence across Asia. No clinical trial pipeline; all major offerings are commercial.

Therapeutic areas: OncologyOphthalmologyOther
Modalities: Small moleculeHerbal medicineDevice
Industry: Non-Academic Healthcare

Partnerships

Europharm/Jacobson Pharma Corporation Limited – licensing agreement for certain branded healthcare products

Beyond the preview

Go deeper on JBM Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JBM Healthcare.

Explore the full profile